Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR | P06401 | 5/20 | 0.46 |
| ▸ | NR3C1 | P04150 | 5/20 | 0.44 |
| ▸ | AR | P10275 | 4/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 14/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8407238 | 0.85 | PGR (0.62) | PGRNR3C1ARCYP19A1CYP3A4 | |
| SCHEMBL10448763 | 0.80 | PGR (0.45) | PGRNR3C1ARCYP19A1CYP3A4 | |
| SCHEMBL9019843 | 0.80 | PGR (0.42) | PGRNR3C1ARCYP19A1CYP3A4 | |
| SCHEMBL7862313 | 0.80 | CYP19A1 (0.46) | CYP19A1 | |
| SCHEMBL23768679 | 0.79 | CYP19A1 (0.45) | CYP19A1 | |
| SCHEMBL7862407 | 0.77 | CYP19A1 (0.44) | CYP19A1 | |
| SCHEMBL10943585 | 0.76 | CYP19A1 (0.45) | CYP19A1 | |
| SCHEMBL23381659 | 0.76 | PGR (0.62) | PGRNR3C1ARCYP19A1CYP3A4 | |
| SCHEMBL8537252 | 0.76 | CYP19A1 (0.47) | PGRARCYP19A1CYP3A4 | |
| SCHEMBL18528916 | 0.76 | PGR (0.38) | PGRNR3C1ARCYP19A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0404283-B1 | 11-Beta-aryl-4-estrene, method for its production and its use as a medicine | SCHERING AG (DE) | 1996-05-08 | — | — | EP | disclosed |
| EP-0404283-A2 | 11-Beta-aryl-4-estrene, method for its production and its use as a medicine | SCHERING AKTIENGESELLSCHAFT (DE) | 1990-12-27 | — | — | EP | disclosed |